The genetic polymorphisms of HER-2 and the risk of lung cancer in a Korean population

BMC Cancer

Volumn 8, Issue , 2008, Pages

  Jo, Uk ^a,b   Han, Sle Gi Lo ^a,b   Seo, Jae Hong ^a   Park, Kyong Hwa ^a   Lee, Jae Won ^c   Lee, Hyo Jung ^c   Ryu, Jeong Seon ^d   Kim, Yeul Hong ^a,b  

^a Korea University College of Medicine   (South Korea)

^b Korea University College of Medicine   (South Korea)

^c Korea University   (South Korea)

^d Inha University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; CYSTEINE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GUANINE; THYMINE; ERBB2 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; DRINKING BEHAVIOR; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; HUMAN; KOREA; LUNG ADENOCARCINOMA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; POPULATION RESEARCH; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; GENETICS; GENOTYPE; LUNG TUMOR; RISK FACTOR; SMOKING;

ALCOHOL DRINKING; FEMALE; GENOTYPE; HUMANS; KOREA; LUNG NEOPLASMS; MALE; POLYMORPHISM, GENETIC; RECEPTOR, ERBB-2; RISK FACTORS; SMOKING;

EID: 63549089818     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-8-359     Document Type: Article

References (35)

1. Parkin DM Bray FI Devesa SS Cancer burden in the year 2000. The global picture Eur J Cancer 2001, 37(Suppl 8):S4-66 10.1016/ S0959-8049(01)00267-2 11602373
2. Kim HK Lung Cancer in Korea Cancer Res Treat 2002, 34:1-2
3. Shields PG Harris CC Cancer risk and low-penetrance susceptibility genes in gene-environment interactions J Clin Oncol 2000, 18:2309-2315 10829052
4. Bond GL Hu W Bond EE Robins H Lutzker SG Arva NC Bargonetti J Bartel F Taubert H Wuerl P A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans Cell 2004, 119:591-602 10.1016/j.cell.2004.11.022 15550242
5. Erichsen HC Chanock SJ SNPs in cancer research and treatment Br J Cancer 2004, 90:747-751 10.1038/sj.bjc.6601574 14970847
6. Kiyohara C Otsu A Shirakawa T Fukuda S Hopkin JM Genetic polymorphisms and lung cancer susceptibility: A review Lung Cancer 2002, 37:241-256 10.1016/S0169-5002(02)00107-1 12234692
7. Spinola M Meyer P Kammerer S Falvella FS Boettger MB Hoyal CR Pignatiello C Fischer R Roth RB Pastorino U et al.: Association of the PDCD5 locus with lung cancer risk and prognosis in smokers J Clin Oncol 2006, 24:1672-1678 10.1200/JCO.2005.04.4339 16549820
8. Kim JH Kim H Lee KY Choe KH Ryu JS Yoon HI Sung SW Yoo KY Hong YC Genetic polymorphisms of ataxia telangiectasia mutated affect lung cancer risk Hum Mol Genet 2006, 15:1181-1186 10.1093/hmg/ddl033 16497724
9. Akiyama T Sudo C Ogawara H Toyoshima K Yamamoto T The product of the human c-erbB-2 gene: A 185-kilodalton glycoprotein with tyrosine kinase activity Science 1986, 232:1644-1646 10.1126/science.3012781 3012781
10. Bargmann CI Hung MC Weinberg RA The neu oncogene encodes an epidermal growth factor receptor-related protein Nature 1986, 319:226-230 10.1038/ 319226a0 3945311
11. Bae NC Chae MH Lee MH Kim KM Lee EB Kim CH Park TI Han SB Jheon S Jung TH et al.: EGFR, ERBB2, and KRAS mutations in Korean non-small cell lung cancer patients Cancer Genet Cytogenet 2007, 173:107-113 10.1016/ j.cancergencyto.2006.10.007 17321325
12. Yu D Hung MC Overexpression of ErbB2 in cancer and ErbB2-targeting strategies Oncogene 2000, 19:6115-6121 10.1038/sj.onc.1203972 11156524
13. Micke P Hengstler JG Ros R Bittinger F Metz T Gebhard S Beeh KM Oesch F Buhl R c-erbB-2 expression in small-cell lung cancer is associated with poor prognosis Int J Cancer 2001, 92:474-479 10.1002/ijc.1229 11304679
14. Benusiglio PR Lesueur F Luccarini C Conroy DM Shah M Easton DF Day NE Dunning AM Pharoah PD Ponder BA Common ERBB2 polymorphisms and risk of breast cancer in a white British population: A case-control study Breast Cancer Res 2005, 7:R204-209 1064135 15743501 10.1186/bcr982
15. Puputti M Sihto H Isola J Butzow R Joensuu H Nupponen NN Allelic imbalance of HER2 variant in sporadic breast and ovarian cancer Cancer Genet Cytogenet 2006, 167:32-38 10.1016/j.cancergencyto.2004.09.023 16682283
16. Han W Kang D Lee JE Park IA Choi JY Lee KM Bae JY Kim S Shin ES Lee JE et al. A haplotype analysis of HER-2 gene polymorphisms: Association with breast cancer risk, HER-2 protein expression in the tumor, and disease recurrence in Korea Clin Cancer Res 2005, 11:4775-4778 10.1158/ 1078-0432.CCR-04-2208 16000574
17. An HJ Kim NK Oh D Kim SH Park MJ Jung MY Kang H Kim SG Lee KP Lee KS Her2 genotype and breast cancer progression in Korean women Pathol Int 2005, 55:48-52 10.1111/j.1440-1827.2005.01789.x 15693849
18. Xie D Shu XO Deng Z Wen WQ Creek KE Dai Q Gao YT Jin F Zheng W Population-based, case-control study of HER2 genetic polymorphism and breast cancer risk J Natl Cancer Inst 2000, 92:412-417 10.1093/jnci/ 92.5.412 10699071
19. Gabriel SB Schaffner SF Nguyen H Moore JM Roy J Blumenstiel B Higgins J DeFelice M Lochner A Faggart M et al.: The structure of haplotype blocks in the human genome Science 2002, 296:2225-2229 10.1126/science.1069424 12029063
20. Tommasi S Fedele V Lacalamita R Bruno M Schittulli F Ginzinger D Scott G Eppenberger-Castori S Calistri D Casadei S et al.: 655Val and 1170Pro ERBB2 SNPs in familial breast cancer risk and BRCA1 alterations Cell Oncol 2007, 29(3):241-248 17452776
21. Canoz O Ozkan M Arsav V Er O Coskun HS Soyuer S Altinbas M The role of c-erbB-2 expression on the survival of patients with small-cell lung cancer Lung 2006, 184:267-272 10.1007/s00408-005-2591-y 17235726
22. Cassidy A Duffy SW Myles JP Liloglou T Field JK Lung cancer risk prediction: A tool for early detection Int J Cancer 2007, 120:1-6 10.1002/ijc.22331 17058200
23. Koo LC Ho JH Lee N An analysis of some risk factors for lung cancer in Hong Kong Int J Cancer 1985, 35:149-155 10.1002/ijc.2910350202 3972468
24. Lam WK Lung cancer in Asian women-the environment and genes Respirology 2005, 10:408-417 10.1111/j.1440-1843.2005.00723.x 16135162
25. Fraumeni JF Jr Epidemiological opportunities in alcohol-related cancer Cancer Res 1979, 39:2851-2852 445491
26. Wakai K Nagata C Mizoue T Tanaka K Nishino Y Tsuji I Inoue M Tsugane S Alcohol drinking and lung cancer risk: An evaluation based on a systematic review of epidemiologic evidence among the Japanese population Jpn J Clin Oncol 2007, 37(3):168-174 10.1093/jjco/hyl146 17332056
27. Suzuki T Matsuo K Hiraki A Saito T Sato S Yatabe Y Mitsudomi T Hida T Ueda R Tajima K Impact of one-carbon metabolism-related gene polymorphisms on risk of lung cancer in Japan: A case control study Carcinogenesis 2007, 28(8):1718-1725 10.1093/carcin/bgm104 17468511
28. Lynch TJ Bell DW Sordella R Gurubhagavatula S Okimoto RA Brannigan BW Harris PL Haserlat SM Supko JG Haluska FG et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib N Engl J Med 2004, 350:2129-2139 10.1056/NEJMoa040938 15118073
29. Paez JG Janne PA Lee JC Tracy S Greulich H Gabriel S Herman P Kaye FJ Lindeman N Boggon TJ et al EGFR mutations in lung cancer: Correlation with clinical response to gefitinib therapy Science 2004, 304:1497-1500 10.1126/science.1099314 15118125
30. Shigematsu H Takahashi T Nomura M Majmudar K Suzuki M Lee H Wistuba II Fong KM Toyooka S Shimizu N et al. Somatic mutations of the HER2 kinase domain in lung adenocarcinomas Cancer Res 2005, 65(5):1642-1646 10.1158/ 0008-5472.CAN-04-4235 15753357
31. Millikan RC Hummer AJ Wolff MS Hishida A Begg CB HER2 codon 655 polymorphism and breast cancer: Results from kin-cohort and case-control analyses Breast Cancer Res Treat 2005, 89:309-312 10.1007/ s10549-004-2171-5 15754131
32. Hynes NE Lane HA ERBB receptors and cancer: The complexity of targeted inhibitors Nat Rev Cancer 2005, 5:341-354 10.1038/nrc1609 15864276
33. Fleishman SJ Schlessinger J Ben-Tal N A putative molecular-activation switch in the transmembrane domain of erbB2 Proc Natl Acad Sci USA 2002, 99:15937-15940 138543 12461170 10.1073/pnas.252640799
34. Ameyaw MM Tayeb M Thornton N Folayan G Tariq M Mobarek A Evans DA Ofori-Adjei D McLead HL Ethnic variation in the HER-2 codon 655 genetic polymorphism previously associated with breast cancer J Hum Genet 2002, 47:172-175 10.1007/s100380200019 12166652
35. Zabaleta J Schneider BG Ryckman K Hooper PF Camargo MC Piazuelo MB Sierra RA Fontham ET Correa P Williams SM et al.: Ethnic differences in cytokine gene polymorphisms: Potential implications for cancer development Cancer Immunol Immunother 2007